This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
Weight LossPeptide vialTriple agonistResearchWeight Loss
UPA Retatrutide
Triple agonist. The most-studied next-wave weight-loss peptide.
R 2 610
30 mg vial
Triple mechanismActivates GIP, GLP-1 and glucagon receptors simultaneously.
Highest trial resultsPhase 2 trials reported the largest weight reductions to date in class.
Metabolic upgradeGlucagon arm increases energy expenditure in addition to appetite control.
Full-spectrum supportImproves glucose, lipids, and liver fat markers.
Retatrutide adds glucagon-receptor activation on top of the dual GIP/GLP-1 mechanism. Glucagon at these levels increases basal metabolic rate and hepatic fat oxidation — complementing appetite suppression with real energy expenditure.
More in Weight Loss
You might also like
Weight LossR 195
90 capsules
Natural Fat Burner
A daily botanical + thermogenic capsule designed to support metabolism and an active routine — from the Slender Living line.
View details →
Weight LossR 669
30 capsules
S30 Extreme Fat Burner
An extreme thermogenic fat-burner capsule — formulated for serious weight-loss routines and hard-training days.
View details →
Weight LossR 689
30 capsules
V30 Hardcore Fat Burner
A hardcore fat-burner capsule for advanced users — intense thermogenic support to push past plateaus.
View details →
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.